Evidence map›Paper›PMID 27127177›Full record

ArticleOncotarget2016

Ninjurin1 inhibits colitis-mediated colon cancer development and growth by suppression of macrophage infiltration through repression of FAK signaling.

Jong Kyu Woo, Yeong-Su Jang, Ju-Hee Kang, Jong-Ik Hwang, Je Kyung Seong, Sang-Jin Lee, Sejin Jeon, Goo Taeg Oh, Ho-Young Lee, Seung Hyun Oh

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Ninjurin 1 has two opposing functions in tumorigenesis in a p53-dependent manner.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Jong Kyu WooCollege of Pharmacy, Gachon University, Incheon, Republic of Korea.
Yeong-Su JangCollege of Pharmacy, Gachon University, Incheon, Republic of Korea.
Ju-Hee KangCollege of Pharmacy, Gachon University, Incheon, Republic of Korea.
Jong-Ik HwangGraduate School of Medicine, Korea University, Seoul, Republic of Korea.
Je Kyung SeongCollege of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
Sang-Jin LeeNational Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea.
Sejin JeonDepartment of Life sciences, Ewha Womans University, Seoul, Republic of Korea.
Goo Taeg OhDepartment of Life sciences, Ewha Womans University, Seoul, Republic of Korea.
Ho-Young LeeCollege of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Seung Hyun OhCollege of Pharmacy, Gachon University, Incheon, Republic of Korea.
Gachon University · KRSeoul National University · KREwha Womans University · KRKorea University · KRNational Cancer Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophage infiltration promotes tumorigenesis. However, the macrophage infiltration regulatory molecules have not been fully determined. Nerve injury-induced protein 1 (ninjurin1) is a homophilic cell surface adhesion molecule that plays an important role in cell migration and attachment. Although ninjurin1 is believed to play a role in several malignancies, it is unclear whether ninjurin1 expression contributes to cancer progression. We used transgenic mice (tg mice) that overexpressed ninjurin1 on macrophages. We subjected ninjurin1 tg mice to a well-known mouse model of colitis-associated colon cancer in which animals are treated with azoxymethane (AOM) and dextran sulfate sodium (DSS). After AOM and DSS treatment, ninjurin1 tg mice developed fewer and smaller tumors compared with wild-type (wt) mice. Ninjurin1 tg mice also showed reduced infiltration of macrophages and suppressed angiogenesis in the tumor mass. We therefore explored whether ninjurin1 decreases macrophage migration into the tumor sites. After adoptive transfer to tumor-bearing recipients, wild type and ninjurin1 tg mice's peritoneal macrophages were freshly isolated and labeled with carboxyfluorescein succinimidyl ester (CFSE). As expected, compared with that of wt type macrophages, tumor infiltration of ninjurin1-overexpressing macrophages was significantly decreased. We also found that ninjurin1 overexpression suppressed FAK activity. In addition, knockdown of ninjurin1 enhanced FAK activity and migration activity of RAW264.7 cells. Ninjurin1 overexpression on macrophage inhibits tumor growth by suppression of macrophage infiltration through repression of FAK signaling. Ninjurin1 is a key regulator molecule for macrophage migration and Tumor-associated macrophages (TAM) mediated tumorigenesis in vivo.

Indexed as

AnimalsCell Adhesion Molecules, NeuronalCell MovementColitisColonic NeoplasmsFocal Adhesion Kinase 1MacrophagesMiceMice, TransgenicNerve Growth FactorsRAW 264.7 CellsCell Adhesion Molecules, NeuronalFocal Adhesion Kinase 1Nerve Growth FactorsNinj1 protein, mousePtk2 protein, mousecolitis-associated colon cancer model (CAC)colon cancerfocal adhesion kinase (FAK)macrophageninjurin1

Identifiers

PMID27127177
PMCPMC5045419
OpenAlexW2345111974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.